Todd Franklin Watanabe, the President and Chief Executive Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), recently sold 19,301 shares of the company's common stock. The shares were sold at an ...

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT )执行副总裁兼首席医疗官Patrick Burnett近期出售了12,116股公司普通股。该交易于2025年2月3日执行，平均成交价为每股12.70美元，总售价约为153,873美元。此次出售发生之际，ARQT股票表现强劲，过去一年回报率达117%。根据 InvestingPro ...

近期，Arcutis Biotherapeutics Inc. (NASDAQ: ARQT )的董事Howard G. Welgus出售了10,000股公司普通股。这些股票以加权平均价格$12.71售出，交易总额达$127,100。此次交易发生之际，ARQT表现出强劲势头，过去一年股票回报率达117%。根据 InvestingPro 数据显示，该公司保持着接近90%的强劲毛利率。此次出售后，Wel ...

Gene “Daddy G” Barge, an admired and durable saxophone player, songwriter and producer who worked on hits by Natalie Cole, oversaw recordings by Muddy Waters, performed with the ...

LOS ANGELES, CA / ACCESS Newswire / February 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...

A webcast of Sensei’s presentation will be available in the Investors section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event.

Management is scheduled to give a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 11, 2025 at 10:15 AM EST at the Royale Room and will be available to participate in ...